H

Haemonetics Corp

HAE

90.260
USD
0.08
(0.09%)
مغلق
حجم التداول
15,627
الربح لكل سهم
0
العائد الربحي
0
P/E
33
حجم السوق
3,809,670,519
أصول ذات صلة
A
ABMD
0
(0%)
0.000000 USD
B
BAX
0.190
(0.53%)
36.000 USD
BDX
-4.995
(-2.07%)
236.055 USD
BSX
1.315
(1.78%)
75.170 USD
EW
-1.220
(-1.94%)
61.830 USD
ISRG
6.98
(1.57%)
451.27 USD
MDT
0.160
(0.20%)
80.470 USD
SYK
5.59
(1.71%)
332.94 USD
TMO
9.03
(1.47%)
621.78 USD
UNH
-3.71
(-0.64%)
572.45 USD
Z
ZBH
-0.280
(-0.25%)
111.100 USD
الأخبار المقالات

العنوان: Haemonetics Corp

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, thecompany operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.